Controversies in antimicrobial prophylaxis

Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|June 1, 1987
PubMed

Insights

Surgical antimicrobial prophylaxis guidelines are debated. Generally, a single dose is sufficient, postoperative doses are unnecessary, and third-generation cephalosporins lack evidence for prophylaxis. Optimal strategies vary, especially for colorectal surgery and patients with implants.

Area of Science:

  • Infectious Diseases
  • Surgical Practice
  • Pharmacology

Background:

  • Antimicrobial prophylaxis is crucial for preventing surgical site infections.
  • Controversies exist regarding optimal antimicrobial prophylaxis strategies.
  • Current guidelines require clarification on several key aspects.

Purpose of the Study:

  • To examine controversies in antimicrobial prophylaxis.
  • To provide evidence-based recommendations for surgical prophylaxis.
  • To clarify optimal strategies for specific patient populations and procedures.

Main Methods:

  • Literature review and critical analysis of existing studies.
  • Examination of evidence regarding prophylaxis duration.
  • Evaluation of specific antibiotic classes and their efficacy.
  • Analysis of prophylaxis in high-risk surgical procedures and patient groups.

Main Results:

  • A single preoperative or intraoperative dose of antimicrobial agents is generally sufficient; postoperative doses are typically unnecessary.
  • No clinical evidence supports the use of third-generation cephalosporins for surgical prophylaxis.
  • Optimal prophylaxis for colorectal surgery may involve a combination of oral and parenteral antibiotics.
  • Prophylaxis is generally not indicated for procedures causing transient bacteremia in patients with prosthetic joints or vascular grafts, but established infections require prompt treatment.

Conclusions:

  • Antimicrobial prophylaxis duration should be limited to the intraoperative period.
  • Third-generation cephalosporins should not be used for surgical prophylaxis due to lack of evidence.
  • Tailored prophylaxis strategies are necessary for specific surgical contexts, such as colorectal surgery.
  • Careful consideration of risks and benefits is needed for prophylaxis in patients with implants.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...